Of the total population admitted over a 12-month period to a tertiary referral epilepsy centre for assessment of their seizure disorder, a high percentage were diagnosed with non-epileptic attack disorder. A retrospective analysis of these patients revealed that although intensive therapy and support was offered during the period of admission, the long-term resources for further management post-discharge were inadequate and in some cases non-existent. The implications for patient satisfaction with the service being offered are discussed and a patient information booklet produced in response to the findings is available by writing to the first author (H.R.).
INTRODUCTION
The notion of non-organically based seizure-like behaviour is thought to have been documented as far back as Hippocrates around 400 BC. The term 'pseudoseizure' has been used to describe this phenomenon for more than 30 years, yet a cursory glance at the literature makes evident that even a basic issue, such as the appropriate terminology to use, remains unresolved. Here, the term 'non-epileptic attack disorder' or NEAD will be used to denote those attacks that are due to organic causes other than epilepsy, e.g. cardiovascular problems, those which are caused by panic, anxiety or hyperventilation, and finally those which are emotionally based such as swoons, tantrums and abreactive attacks.
Research into NEAD can be broadly categorized into three areas: establishing diagnostic criteria, determining prevalence and psychological/hehavioural profiling. The diagnosis of NEAD is fraught with difficulty and it remains essentially a diagnosis of exclusion. The various definitions of non-epileptic attack disorder have as their common denominator that there is no known organic basis to the attacks, or if there is, there is no concomitant EEG evidence of epilepsy. It is an example of a clinical phenomenon where a multidisciplinary approach is essential. Despite the amount of effort that is being put into establishing diagnostic criteria for NEAD, at present there is no international consensus for what these should be.
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ways of diagnosing NEAD, that those studies looking at incidence data (number of new episodes of sickness in a population over an estimated period) or prevalence rates (current sickness in a population) have reported very different results. A review of epidemiological data' illustrates this well. Estimates of the prevalence of non-epileptic attack disorder range from l-30% of patients seen in the context of outpatient epilepsy clinics or those referred to specialist inpatient facilities.
Research that has focused on distinguishing epilepsy from non-epileptic attack disorder by exploring demographic, psychological or behavioural differences across the two groups, suffers from the same problem of a lack of diagnostic and methodological consistency across studies. For example, it was received wisdom that non-epileptic attacks tend to occur in younger individuals (i.e. those below the age of 40), and also that women tend to present with non-epileptic attacks more often than men, and finally that NEAD occurs more often in those individuals with a pre-existing history of psychiatric or neurological problems. Unfortunately, each and every one of these generalizations has received only equivocal support over the years.
It is perhaps because researchers have been preoccupied with the more basic issues of diagnosis and prevalence that questions of clinical outcome in this area have been relatively neglected. The few studies that have addressed this issue have tended to focus on assessing outcome by using measures such as change in seizure frequency'" , and less often, changes in quality of life4* 5.
The present study focuses on these traditional outcome measures, as well as exploring patient satisfaction with the service provided. In a recent article6, it was pointed out that since an internal market model now operates within the NHS, customer, or in this case patient satisfaction could be regarded as being as important an outcome measure as clinical improvement.
In the past, a number of studies have considered whether and to what extent patients with epilepsy are satisfied with the services they have access to, by asking about how the diagnosis was communicated, how much advice was given about medication issues, and whether information was provided about the availability of local support agencies. The findings have been fairly consistent, with the overall majority of epilepsy patients being happy with what was currently available7-lo.
One of the most comprehensive studies6 recently followed up three cohorts of patients from a UK tertiary referral centre in south-east London using questionnaires. The results were reported from the sample as a whole, which included people with epilepsy, with epileptic and non-epileptic attacks and those with nonepileptic attacks only. Patients were asked to comment on whether and to what extent their condition had improved since discharge and what value they placed on the admission in retrospect. The authors concluded that the most significant finding from their study was that the longer the admission, the more likely that it was perceived as being of greater value.
It was certainly not clear from this study how perceptions of the service differed across the various diagnostic groups. Unfortunately, the needs of those with non-epileptic attack disorder have rarely been explicitly addressed. Given that many of those diagnosed with NEAD have often been told somewhere down the line that they suffered from epilepsy, and given how much some of these patients have invested in a diagnosis of epilepsy, one could speculate that those who are eventually told that their seizures are non-epileptic may not only be less accepting of the diagnosis, but also more resistant to treatment recommendations. The present study explored how patients who were diagnosed with NEAD felt about the diagnosis and treatment offered to them.
MATERIALS AND METHODS

The David Lewis Centre
This is a specialist inpatient facility where individuals are admitted for periods of up to 6 weeks, primarily for assessment of their seizure disorders. A combination of investigative techniques are employed to ensure the accuracy of the diagnosis and this forms the basis of recommendations for treatment regimes. Referrals are usually the result of poorly managed epilepsy with a history of poor response to medication. At the end of the assessment period, conclusions are drawn and the treatment proposals are relayed to the patient and the referring agent using a non-confrontational approach5.
Subjects
A casenote analysis was conducted to identify all those who are diagnosed with NEAD from April 1996-97. These individuals were written to for consent and once obtained, data collection took place in two parts.
Retrospective data were obtained from the medical notes. This included details of gender, age and marital status. Information was also recorded about the age of onset of the attacks, together with any vulnerability factors such as a family history of epilepsy or psychiatric problems, significant life events at the time of onset, previous sexual, physical or emotional abuse, etc. Information was also collated about frequency of attacks on admission, the diagnosis on discharge (i.e. whether all attacks were non-epileptic or whether there was evidence of epileptic seizures as well). Finally, data on the frequency of attacks on discharge and treatment offered were also documented.
Prospective data were obtained by contacting each of the patients by telephone and conducting a semistructured interview. The areas covered included the current frequency of seizures and whether there had been a subjective increase or decrease in the number of seizures and/or quality of life since involvement with the service. Patients were also asked to indicate how they remembered feeling when they were initially told the diagnosis and their immediate reaction to the treatment recommendations. Finally, they were asked to comment on whether they felt differently about the diagnosis and treatment now.
RESULTS
Sample size and demographics
Of a total of 91 patients who were admitted to the assessment unit for investigations during the time of the study, NEAD was diagnosed in 25 patients (27.5%). When these patients were written to, seven did not reply and three, although consenting, were not available for follow-up data. The final sample size for the purposes of this study was 15. The mean length of follow-up from the time of admission to the time of being contacted for the purpose of the study was 13.8 months (range: 8-21 months). The characteristics of those patients who took part are presented in Table 1 .
Seizure frequency Reaction to diagnosis and treatment
A case-by-case analysis of the change in seizure frequency was conducted, so that for each of the 15 patients in the sample, a comparison was made between seizure frequency at admission and seizure frequency at follow-up. The data were collated into four outcome categories presented in Table 2 . If a positive clinical outcome is taken as being either seizure cessation or a reduction in seizure frequency of over 50%, then 61% of the sample could be said to have significantly improved at follow-up. When these data were compared with the subjective experiences of patients (Table 3) , it was apparent that the majority of the sample reported that there had been a significant decrease in seizure frequency since admission to the unit. When asked how this improvement in clinical status translated to improved quality of life (QoL), two-thirds of the sample reported that their QoL had also improved since admission. Patients were asked to provide details of their reactions to the diagnosis and the treatment offered at the time of discharge and whether their perceptions had changed during the follow-up period. For each patient, these essentially qualitative data were characterized into a primarily positive response, a primarily negative response or a mixed response. It was found that an overwhelming majority reported that they either had a negative or a mixed reaction to a diagnosis of NEAD at the time of discharge (Table4). Furthermore, almost three-quarters of the sample reported that they continued to feel this way at follow-up. With regards to treatment, patients were asked what, if any, services they had been in contact with since discharge. The responses fell broadly into three categories, with 20% of the sample being seen by a psychiatrist post-discharge, 40% being folldwed up in the context of epilepsy clinics (50% of these had epilepsy specialist nursing input). The remaining 40% of the sample reported having no contact with specialist services after discharge. Furthermore, two-thirds of the sample reported that at the time of discharge, they had a negative or mixed reaction to the treatment being offered and when asked how they currently felt, just under half of the sample continued to express negative or mixed feelings about the treatment options available (Table 4) .
DISCUSSION
Recognition that the diagnosis and management of patients suffering from non-epileptic attack disorder is a complicated business has meant that such patients are increasingly investigated in the context of tertiary referral units. Multidisciplinary input and a consistent approach by all concerned is generally agreed to be a prerequisite of an effective assessment facility' ' . Unfortunately, by virtue of being a specialist service, patients may be referred from a large geographical area. Therefore, although care during the admission may well be appropriate for this patient group, it is far from clear whether and to what extent the multifaceted and complicated needs of these patients are addressed postdischarge. The aim of this study was to explore how patients felt about the way their care had been managed following a diagnosis of non-epileptic attack disorder.
With regards to traditional outcome measures, the results of this study indicated that over one-quarter of the sample were found to be seizure-free on follow-up and that a further 40% had experienced a sizeable reduction in seizure frequency (i.e. above 50%). This compares favourably with the results of other studies2T4.
It has been proposed2 that a better outcome is associated with a longer follow-up period. Unfortunately, because follow-up periods varied for subjects in this study, it was not possible to explore this, but certainly future work would do well to clarify this issue further by controlling for length of follow-up period, as well as operationalizing terms such as 'significant reduction' or 'occasional non-epileptic attacks' when referring to outcome data.
It was heartening to find that when these quantitative data were compared with the subjects' perception of changes in clinical status since admission to the unit, the results were broadly consistent. Furthermore, as one would expect, improved clinical status translated to improved QoL5* ". If this is where it stopped, it would not be unreasonable to think that the majority of the sample perceived the service as being of some value.
However, despite the rationale underlying the diagnosis and treatment recommendations being clearly communicated to all patients at the time of discharge, using an approach that is aimed at empowering the individual whilst engendering control, almost tbreequarters of the sample were clearly unhappy or had mixed feelings about being told that their seizures were not due to epilepsy. Furthermore, just under half were not happy about the treatment that had been made available to them following discharge. When qualitative data were analysed, it was striking that patients remained confused, misinformed and held maladaptive misconceptions about the nature of non-epileptic attack disorder. It was felt that this raised some very important questions about patient needs and the extent to which these are being met by existing service input and this led to the development of an information booklet for patients diagnosed with NEAD.
This was produced in response to the comments made by the patients who took part in the study. It aimed to address the questions that were felt to have been left unanswered after discharge. The booklet is divided into various sections covering the causes of NEAD, diagnosis, treatment options and information about professional groups who might be approached with regards to intervention. It is intended to be a first edition, to be H. Riaz et a/ revised in light of the feedback from the patients who took part in the study and clinicians with a specialist interest in the area.
Finally, the authors felt that patients with NEAD required ongoing access to information about the nature of the disorder. Furthermore, it was also felt that this was a group that would benefit from long-term outpatient support, so the use made of available tratment options could be monitored.
